WOBURN, Mass., Jan. 24, 2025 /PRNewswire/ — Curiox Biosystems, a global leader in providing innovative and automated sample preparation solutions for accurate and reproducible cell analysis, is pleased to announce the launch of the Curiox C- Free Pluto ALPHA, the latest addition to the Pluto line of products. This compact and intuitive device redefines cell washing automation, bringing simplicity, reliability, and affordability to labs of all sizes.
Revolutionizing Cell Washing
The Curiox C- Free Pluto ALPHA replaces traditional centrifuge-based methods, offering a low-maintenance solution that eliminates bulky hardware. Utilizing a pipette head, it delivers gentle, consistent washing of suspension cells and beads, preserving sample integrity and improving reproducibility. By simplifying workflows and reducing variability, Curiox C- Free Pluto ALPHA helps researchers achieve more consistent, high-quality results in less time.
Key Features
Workflow Benefits
Pre-configured with Light, Moderate, Heavy, and Ultra wash protocols, the Curiox C- Free Pluto ALPHA minimizes hands-on time for researchers, allowing them to focus on high-value tasks. The elimination of centrifugation, flicking, or resuspension steps streamlines workflows while ensuring reproducibility across experiments. These features are especially valuable for immunophenotyping, cell therapy, and drug discovery applications.
Empowering Labs with the Pluto Line
The Pluto product line reflects Curiox’s mission to drive innovation and enhance productivity. With a focus on scalability and adaptability, Pluto devices cater to diverse research and clinical needs. Whether for small-scale studies or industrial-scale operations, Curiox C- Free Pluto ALPHA is a critical step in advancing automated cell washing solutions.
Configurations to Suit Every Need
Experience Curiox C- Free Pluto ALPHA
“The Curiox C- Free Pluto ALPHA combines affordability, simplicity, and precision, enabling labs of all sizes to achieve consistent, reliable results while saving time and resources,” said Dr. Namyong Kim, CEO & CTO at Curiox Biosystems. “This device embodies our commitment to providing accessible automation solutions that elevate research capabilities.”
Curiox invites researchers and industry leaders to discover the transformative capabilities of the Curiox C- Free Pluto ALPHA in person at SLAS2025 between Jan 26-29th at our booth#113. Visit Pluto ALPHA to explore features, watch live demonstrations, and contact us for more information.
About Curiox Biosystems Co. Ltd
Curiox Biosystems Co. Ltd is a rapidly growing global biotechnology company specializing in advanced sample preparation solutions that enhance next-generation therapies. The company leverages expertise in surface chemistry and instrumentation to address life-science research challenges, particularly in miniaturization and automation. Curiox’s innovative technologies boost productivity through sample preparation automation, speeding up therapeutic development. Committed to advancing its proprietary C-FREE™ technology, Curiox enables significant scientific breakthroughs, reinforcing its role as a key player in transforming life sciences research and diagnostics worldwide.
For more information, visit https://www.curiox.com/ or contact:
[Mahrukh M Banday, PhD]
[Executive Vice President /General Manager]
[mahib@curiox.com]
[+17814915289]
SOURCE Curiox Biosystems
– Largest hypertension trial of an aldosterone synthase inhibitor to date demonstrated the efficacy of…
Oslo, 24 May 2025: Zelluna ASA (the "Company") refers to the resolution by the Company's…
Los Angeles, CA and Vancouver, BC, May 23, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc.…
$3.25 million upfront with up to an additional $6.5 million of potential aggregate gross proceeds upon…
INDIANAPOLIS, May 23, 2025 /PRNewswire/ -- This Memorial Day Weekend, the spotlight won't only be on…
IRVING, Texas, May 23, 2025 /PRNewswire/ -- Caris Life Sciences® ("Caris"), a leading, patient-centric, next-generation AI…